September 24, 2015

Aurobindo Pharma on Thursday announced that the Food and Drug Administration had approved its generic of AstraZeneca’s Prilosec (omeprazole) delayed-release capsules. 

September 22, 2015

Impax Laboratories announced Tuesday that the Food and Drug Administration had approved its generic of Valeant’s Testred (methyltestosterone) capsules.

September 21, 2015

For the U.S. pharmaceutical market, 2015 is already shaping up to be another double-digit growth year in terms of prescription spend, and brand-name specialty drugs are big drivers of that growth.

September 17, 2015

Aurobindo Pharma’s received approval from the Food and Drug Administration this week for its generic of Roxane Laboratories’ Dolophine (methadone HCL) tablets. 

September 17, 2015

While most available apps focus on overall wellness, healthcare systems and professionals are expressing greater interest and excitement in broader app use.

September 16, 2015

Although growth has been high for new specialty and brand-name drugs in the past year, generics continue to be a central part of the U.S. pharmaceutical market.

August 27, 2015

Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths. 

August 26, 2015

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

August 26, 2015

Darren Townzen, Walmart’s director of health-and-wellness systems, and Sam’s Club’s John Luebker, senior director H&W wellness contracting and pricing, are the recipients of this year’s IMS Health Bernie Greenberg Pharmacy Partnership Award. 

August 22, 2015

An executive familiar with the kind of deep data dives that provide actionable insights for OTC companies joins CPR. 

August 21, 2015

The app allows users to find and download IMS Health data and white papers based on its analytics, healthcare expertise and global information assets.

August 20, 2015

Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. It was a landmark in the nation’s social and political development and an evolutionary leap for community pharmacy.

August 12, 2015

Dr. Reddy’s Laboratories has announced the launch and FDA approval of its pramipexole dihydrochloride extended release tablets.

August 5, 2015
Par Pharmaceutical announced Wednesday that the Food and Drug Administration had granted final approval of the company’s generic version of Sodium Edecrin (ethacrynate sodium) for injection.
July 9, 2015

Sandoz has launched its generic version of Angiomax (bivalirudin), an anticoagulant injection. 

April 25, 2015

Anda again hosted a stellar two-day event on the eve of NACDS Annual Meeting, featuring several notable sports celebrities, along with an industry overview from IMS Health’s Doug Long.

April 24, 2015

Sandoz on Friday announced the launch of levoleucovorin injection ready-to-use single use vial, a generic version of Fusilev, which is marketed by Spectrum Pharmaceuticals. 

April 17, 2015

IMS Health is getting ready to launch a consumer version of its AppScript app, according to a MedCityNews report. 

April 14, 2015

Total dollars spent on prescriptions in the U.S. were up 13.1%.

April 9, 2015

Walgreens Boots Alliance on Thursday posted solid same-store sales numbers, driving U.S. sales up 7.4% to $21 billion, but has targeted 200 store closures in a cost-saving initiative. 

March 13, 2015

“Drugs don’t work in patients who don’t take them.”

March 10, 2015

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.